Please assess the completion status of the following clinical trial:

Trial Title: Midodrine for Improving Hemodynamics After Spinal Anesthesia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* • American Society of Anesthesiologists (ASA) status: 1 or 2 .~  * Orthopedic surgery on the lower extremities~Exclusion Criteria:~* • Pheochromocytoma. .Throtoxicosis. .Structural heart disease.~  * Baseline blood pressure more than 140/90 .Acute kidney failure.~ * Any contraindications to spinal anesthesia such as local infection and coagulopathy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Group A (midodrine group) (Type: ACTIVE_COMPARATOR): Midodrine will be given orally with small sips of water one hour before arrival in the operation room before spinal anesthesia
- Group B (placebo group): (Type: PLACEBO_COMPARATOR): Inert tablet containing sugar (placebo) will be given orally with small sips of water one hour before arrival in the operation room before spinal anesthesia

Based on this trial design, predict the completion outcome and termination type (if applicable).